CME Group Inc (NASDAQ:CME) Receives $188.64 Average PT from Analysts

CME Group Inc (NASDAQ:CME) has earned a consensus rating of “Hold” from the seventeen ratings firms that are covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $189.71.

A number of equities research analysts recently commented on CME shares. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $210.00 price objective on shares of CME Group in a research note on Friday, February 15th. JPMorgan Chase & Co. started coverage on CME Group in a research note on Friday, February 15th. They set an “underweight” rating and a $164.00 price objective for the company. Citigroup set a $205.00 price objective on CME Group and gave the stock a “buy” rating in a research note on Friday, February 15th. BidaskClub cut CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, February 20th. Finally, Deutsche Bank decreased their price objective on CME Group from $220.00 to $214.00 and set a “buy” rating for the company in a research note on Friday, March 15th.

Shares of CME stock traded up $0.13 on Wednesday, reaching $198.88. 905,873 shares of the stock were exchanged, compared to its average volume of 1,740,230. The company has a market cap of $71.19 billion, a P/E ratio of 29.16, a PEG ratio of 4.65 and a beta of 0.24. CME Group has a one year low of $158.35 and a one year high of $204.56. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.16.



CME Group (NASDAQ:CME) last released its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.02. The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.19 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.86 earnings per share. As a group, equities research analysts anticipate that CME Group will post 6.59 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be paid a $0.75 dividend. The ex-dividend date is Friday, June 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.51%. CME Group’s payout ratio is 43.99%.

In other CME Group news, Director Elizabeth A. Cook sold 300 shares of the business’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $204.27, for a total value of $61,281.00. Following the completion of the transaction, the director now directly owns 20,821 shares of the company’s stock, valued at $4,253,105.67. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Kevin Kometer sold 16,140 shares of the business’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $201.19, for a total value of $3,247,206.60. Following the completion of the transaction, the insider now directly owns 72,122 shares of the company’s stock, valued at $14,510,225.18. The disclosure for this sale can be found here. Over the last three months, insiders sold 53,813 shares of company stock valued at $10,013,676. Insiders own 1.20% of the company’s stock.

Large investors have recently bought and sold shares of the business. Thor Advisors LLC acquired a new position in shares of CME Group during the first quarter worth about $62,000. Marshall Wace North America L.P. acquired a new position in shares of CME Group during the first quarter worth about $537,000. Marshall Wace LLP boosted its position in shares of CME Group by 210.6% during the first quarter. Marshall Wace LLP now owns 52,069 shares of the financial services provider’s stock worth $8,570,000 after buying an additional 35,306 shares during the period. Rehmann Capital Advisory Group boosted its position in shares of CME Group by 12.9% during the first quarter. Rehmann Capital Advisory Group now owns 6,354 shares of the financial services provider’s stock worth $1,046,000 after buying an additional 727 shares during the period. Finally, IMS Capital Management boosted its position in shares of CME Group by 1.0% during the first quarter. IMS Capital Management now owns 8,114 shares of the financial services provider’s stock worth $1,335,000 after buying an additional 80 shares during the period. 84.76% of the stock is owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: Call Option

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.